4//SEC Filing
Mayer Eldon C. III 4
Accession 0001140361-23-012884
CIK 0001305253other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 9:00 PM ET
Size
6.8 KB
Accession
0001140361-23-012884
Insider Transaction Report
Form 4
Mayer Eldon C. III
Director
Transactions
- Sale
Common Stock
2023-03-17$1.07/sh−2,520$2,696→ 57,948 total - Sale
Common Stock
2023-03-17$1.07/sh−1,875$2,008→ 56,073 total
Footnotes (3)
- [F1]These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units ("RSUs") granted on March 11, 2022 for 16,000 shares.
- [F2]These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 12, 2021 for 11,875 shares.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.07 to $1.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001686952
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 9:00 PM ET
- Size
- 6.8 KB